E22.0
Acromegaly and pituitary gigantism
Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 11 never code together
Instructional notes 2
E22.0code
Inclusion terms
- Overproduction of growth hormone
E00-E89chapter
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 13
- Arthritis, arthritic (acute) (chronic) (nonpyogenic) (subacute) M19.90
- Arthropathy M12.9
- in (due to)
- acromegaly E22.0
- in (due to)
- Acromegaly, acromegalia E22.0
- Syndrome — see also Disease
- Marie's
- disease or syndrome (acromegaly) E22.0
- Erdheim's syndrome (acromegalic macrospondylitis) E22.0
- Hypophyseal, hypophysis — see also condition
- gigantism E22.0
- Gigantism (cerebral) (hypophyseal) (pituitary) E22.0
- Hypersecretion
- hormone (s)
- growth E22.0
- hormone (s)
- Overproduction — see also Hypersecretion
- growth hormone E22.0
- Launois' syndrome (pituitary gigantism) E22.0
- Macrospondylitis , acromegalic E22.0
- Scaglietti-Dagnini syndrome E22.0
Alongside this code 4 same parent — E22
Additional references
AHA Coding Clinic® Licence required
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.